Albeit small, its two to three month increase in survival time (Miller 2007) indicates that controlling glutamate levels in the brain could be an essential component in fighting ALS and provides valuable information toward ultimately finding a more effective treatment for the disease (Carlesi 2011)
& Marin-Garcia, J
This protocol isn't appropriate for patients who are pregnant or nursing, individuals under 18, those with active cancer, or patients with contraindications to GLP-1 medications (medullary thyroid carcinoma history, MEN2 syndrome, history of pancreatitis)
The extensive preclinical research foundation, favorable preclinical safety profile, and preliminary human experience suggest BPC-157 warrants continued investigation as a potential therapeutic agent for tissue repair and regeneration
Blocks the NNMT enzyme that converts nicotinamide to N-methylnicotinamide, preserving nicotinamide for NAD+ synthesis and cellular energy pathways
For such a reason, freezing peptides in solution is generally not recommended unless aliquoted